Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 32Neoplasms 26Depression 21Fatigue 20Prostatic Neoplasms 13Lymphoma, Follicular 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Multiple Myeloma 11Lymphoma, Large B-Cell, Diffuse 10Lung Neoplasms 10Colorectal Neoplasms 10Carcinoma, Non-Small-Cell Lung 10Pain 9Lymphoma, Non-Hodgkin 9Lymphoma, Mantle-Cell 9Lymphoma, Large-Cell, Immunoblastic 9Lymphoma, B-Cell, Marginal Zone 9Leukemia, Myeloid, Chronic-Phase 9Leukemia, Lymphocytic, Chronic, B-Cell 9Hodgkin Disease 9Burkitt Lymphoma 9Anxiety Disorders 9Vomiting 7Nausea 7Leukemia, Myeloid, Acute 7Leukemia, Myeloid, Accelerated Phase 7Leukemia, Hairy Cell 7Head and Neck Neoplasms 7Carcinoma, Ovarian Epithelial 7Blast Crisis 7

Interventions

pembrolizumab 3Nivolumab 2fludarabine 1epacadostat 1bintrafusp alfa protein, human 1atezolizumab 1aldesleukin 1Therapeutics 1Temozolomide 1Neoadjuvant Therapy 1Interleukin-2 1High-Throughput Nucleotide Sequencing 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Microsatellite Instability × Therapeutics × Clear all
NCT03519412 2026-03-03

ARETHUSA

IFOM ETS - The AIRC Institute of Molecular Oncology

Phase 2 Completed
107 enrolled 14 charts
Gastrointestinal

Colorectal Neoplasms, Microsatellite Instability

Data powered by HemOnc (CC BY 4.0) Colophon âš¡